Anavasi Diagnostics: Bryan Crane, Arthur Kirsch, David Vied

Anavasi Diagnostics has elected three outside members to its board of directors, Bryan Crane, Arthur Kirsch, and David Vied. Crane is currently VP, head of system design at Illumina, while Kirsch is a director at biopharmaceutical firm Liquidia. Vied is the global sector leader for the medical devices practice for Korn Ferry and also is the director of Cyanotech, which develops and markets microalgae based supplements. A spinout of the University of Washington, Anavasi focuses on developing molecular diagnostic tests using a proprietary reverse transcriptase method.